Sei Investments Co. purchased a new stake in Orthopediatrics Corp (NASDAQ:KIDS) during the second quarter, according to its most recent filing with the SEC. The fund purchased 4,743 shares of the company’s stock, valued at approximately $126,000.

Other hedge funds and other institutional investors also recently made changes to their positions in the company. Kornitzer Capital Management Inc. KS increased its holdings in shares of Orthopediatrics by 73.1% in the 2nd quarter. Kornitzer Capital Management Inc. KS now owns 76,000 shares of the company’s stock worth $2,025,000 after buying an additional 32,100 shares during the last quarter. First Light Asset Management LLC purchased a new position in shares of Orthopediatrics during the 1st quarter worth about $1,750,000. Stifel Financial Corp purchased a new position in shares of Orthopediatrics during the 1st quarter worth about $196,000. Next Century Growth Investors LLC boosted its stake in shares of Orthopediatrics by 19.6% during the 1st quarter. Next Century Growth Investors LLC now owns 144,715 shares of the company’s stock worth $2,179,000 after purchasing an additional 23,717 shares during the period. Finally, Cortina Asset Management LLC boosted its stake in shares of Orthopediatrics by 54.0% during the 1st quarter. Cortina Asset Management LLC now owns 199,269 shares of the company’s stock worth $3,001,000 after purchasing an additional 69,884 shares during the period. Institutional investors own 40.16% of the company’s stock.

In other Orthopediatrics news, Director Kevin Unger sold 1,000 shares of the business’s stock in a transaction dated Thursday, September 13th. The shares were sold at an average price of $33.22, for a total value of $33,220.00. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. Also, General Counsel Daniel J. Gerritzen sold 9,525 shares of the business’s stock in a transaction dated Wednesday, September 5th. The shares were sold at an average price of $33.73, for a total transaction of $321,278.25. The disclosure for this sale can be found here. 46.10% of the stock is owned by insiders.

Orthopediatrics stock traded down $0.49 during trading hours on Friday, hitting $31.49. The company had a trading volume of 27,875 shares, compared to its average volume of 61,817. The stock has a market cap of $468.64 million and a price-to-earnings ratio of -5.52. The company has a debt-to-equity ratio of 0.60, a current ratio of 5.98 and a quick ratio of 3.61. Orthopediatrics Corp has a 1 year low of $14.00 and a 1 year high of $39.81.

Orthopediatrics (NASDAQ:KIDS) last released its quarterly earnings data on Thursday, August 9th. The company reported ($0.21) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.14) by ($0.07). The company had revenue of $15.10 million during the quarter, compared to analysts’ expectations of $14.27 million. Orthopediatrics had a negative net margin of 61.99% and a negative return on equity of 192.23%. Orthopediatrics’s revenue for the quarter was up 28.0% on a year-over-year basis. Research analysts expect that Orthopediatrics Corp will post -0.96 earnings per share for the current year.

A number of equities analysts recently commented on KIDS shares. William Blair reaffirmed an “outperform” rating on shares of Orthopediatrics in a research note on Wednesday, June 27th. BidaskClub raised shares of Orthopediatrics from a “buy” rating to a “strong-buy” rating in a research note on Friday, August 31st. Zacks Investment Research cut shares of Orthopediatrics from a “hold” rating to a “strong sell” rating in a research note on Tuesday, August 14th. ValuEngine raised shares of Orthopediatrics from a “hold” rating to a “buy” rating in a research note on Thursday, August 2nd. Finally, Piper Jaffray Companies lifted their price target on shares of Orthopediatrics from $24.00 to $30.00 and gave the stock an “overweight” rating in a research note on Thursday, July 5th. One research analyst has rated the stock with a hold rating and six have assigned a buy rating to the company’s stock. The stock presently has a consensus rating of “Buy” and an average price target of $29.25.

Orthopediatrics Profile

OrthoPediatrics Corp., a medical device company, designs, develops, and markets anatomically appropriate implants and devices for the treatment of children with orthopedic conditions in the United States and internationally. The company's products comprise PediLoc, PediPlates, cannulated screws, PediFlex nail, PediNail products, PediLoc tibia products, locking cannulated blades, locking proximal femurs, spica tables, response spine systems, and pediguards; bandloc, a sub-laminar banding system; and sports medicine and other products, such as anterior cruciate ligament and medial patellofemoral ligament systems.

Featured Article: Understanding Average Daily Trade Volume

Institutional Ownership by Quarter for Orthopediatrics (NASDAQ:KIDS)

Receive News & Ratings for Orthopediatrics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Orthopediatrics and related companies with MarketBeat.com's FREE daily email newsletter.